Literature DB >> 3916096

Fascioliasis in Spain: a review of the literature and personal observations.

J A García-Rodriguez, A M Martin Sánchez, J M Fernández Gorostarzu, E J García Luis.   

Abstract

The fascioliasis induced by Fasciola hepatica is a syndrome which has still not been fully clarified in this country, though the different peninsular regions are suitable for completion of the life cycle of the worm; infested animals may found throughout these regions and in almost all of them human fascioliasis has been diagnosed, with the greatest incidence in the Basque Country, Navarra and La-Rioja. This greater appearance is probably related to the dietary habits in those areas, since the consumption of water cress is undoubtedly the principal source of contamination and is entirely responsible for the rest of the epidemiology of the diseases in humans. In the cases studied, the clinical symptoms did not differ from those habitually found in this syndrome. Serological methods have resolved the diagnosis in the acute phase of the disease and furthermore are of great use for monitoring post-treatment evolution. The cases studied by this Department were diagnosed with immunodiffusion, haemagglutination and immunoelectrophoresis techniques and the evolution of the patients was also followed by immunodiffusion and haemagglutination.

Entities:  

Mesh:

Year:  1985        PMID: 3916096     DOI: 10.1007/bf00141804

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  20 in total

1.  [Obstructive jaundice by human hepatic fascioliasis].

Authors:  A Gallardo; J M Saez; G Enriquez
Journal:  Rev Esp Enferm Apar Dig       Date:  1976-10

2.  [Comments on an epidemic of human hepatic distomatosis. Study of 50 cases in a hospital milieu].

Authors:  J Giraudet
Journal:  Presse Med       Date:  1968-01-27       Impact factor: 1.228

3.  [Biliary distomatosis].

Authors:  J S San Julian
Journal:  Rev Esp Enferm Apar Dig       Date:  1970-01-01

4.  [Fasciola hepatica. Presentation of 10 cases].

Authors:  J M Campo; A Milazzo; J Hebrero; M Sanz; P Revillo; J Lasierra
Journal:  Rev Clin Esp       Date:  1984-05-31       Impact factor: 1.556

5.  [Hepatic distomatosis. Course of its development with final parasitic obstructive jaundice].

Authors:  M Sarria Diaz
Journal:  Rev Esp Enferm Apar Dig       Date:  1971-03-15

6.  [Fascioliasis and strongyloidiasis].

Authors:  C Ayensa Dean; F Aizpúrua Echevarría; D Ganchegui Iturriarte; L Michaus Oquiñena; M Lantero Benedicto
Journal:  Rev Clin Esp       Date:  1984-10-15       Impact factor: 1.556

7.  [Fasciola hepatica (apropos of a case)].

Authors:  M Miras Estacio; A del Pozo Camarón; P A Serrano Sánchez; C Marrón; M M Piñeiro; J M Pajares
Journal:  Rev Esp Enferm Apar Dig       Date:  1981-01

8.  [Faciola hepatica in the main bile duct].

Authors:  J Pina Arroyo; J García García; J L Villar Galán; A Gómez Alonso
Journal:  Rev Esp Enferm Apar Dig       Date:  1982-12

9.  [Surgical extraction of liver flukes (Fasciola hepatica) from the common bile duct].

Authors:  A GARCIA BARON
Journal:  Rev Clin Esp       Date:  1950-08-31       Impact factor: 1.556

10.  [Unusual forms of Fasciola hepatica infestation. Report of two cases (author's transl)].

Authors:  C Aguirre Errasti; J Merino Angulo; M Flores Torres; A de los Rios
Journal:  Med Clin (Barc)       Date:  1981-02-10       Impact factor: 1.725

View more
  3 in total

Review 1.  One hundred years of research on the natural infection of freshwater snails by trematode larvae in Europe.

Authors:  Elzbieta Zbikowska; Anna Nowak
Journal:  Parasitol Res       Date:  2009-05-13       Impact factor: 2.289

2.  Evaluation of a 14.5 kDa-Fasciola gigantica fatty acid binding protein as a diagnostic antigen for human fascioliasis.

Authors:  Gamal Allam; Ibrahim R Bauomy; Zeinab M Hemyeda; Thabet F Sakran
Journal:  Parasitol Res       Date:  2011-11-24       Impact factor: 2.289

3.  Decrease in human fascioliasis in Gipuzkoa (Spain).

Authors:  G Cilla; E Serrano-Bengoechea; A Cosme; L Abadía; E Pérez-Trallero
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.